Keyphrases
Adverse Events
20%
Analgesic Use
20%
Antiretroviral
20%
Daily Pain
20%
Global Improvement
20%
HIV Infection
100%
HIV Neuropathy
60%
HIV Viral Load
20%
Injection Pain
40%
Intraepidermal Nerve Fiber Density
40%
Laboratory Indexes
20%
Nerve Fibers
20%
Nerve Growth Factor
100%
Neurological Examination
20%
Neuropathic Pain
40%
Neuropathy
20%
Pain Assessment
20%
Pain Intensity
20%
Pain Scale
20%
Phase II Trial
100%
Placebo
40%
Placebo-controlled Randomized Trial
20%
Positive Treatment
20%
Prescription Pain Medication
20%
Punching
20%
Quantitative Sensory Testing
20%
Recombinant Human Nerve Growth Factor
100%
Regeneration
20%
Sensory Neurons
20%
Sensory Neuropathy
100%
Skin Biopsy
20%
Subcutaneous Injection
20%
Treatment Difference
20%
Treatment Effect
20%
Twice Daily
20%
Unblinding
20%
Medicine and Dentistry
Adverse Event
20%
Human Immunodeficiency Virus
80%
Human Immunodeficiency Virus Infection
100%
Injection Site Pain
40%
Nerve Fiber
60%
Nerve Growth Factor
100%
Neurologic Examination
20%
Neuropathic Pain
40%
Neuropathy
20%
Pain Assessment
40%
Phase II Trials
100%
Placebo
60%
Primary Outcome
20%
Quantitative Sensory Testing
20%
Randomized Controlled Trial
20%
Recombinant Nerve Growth Factor
100%
Sensory Neuropathy
100%
Skin Biopsy
20%
Subcutaneous Injection
20%
Treatment Effect
20%
Pharmacology, Toxicology and Pharmaceutical Science
Adverse Event
20%
Analgesic Agent
40%
HIV
80%
Human Immunodeficiency Virus Infection
100%
Injection Site Pain
40%
Nerve Growth Factor
100%
Neuropathic Pain
40%
Neuropathy
20%
Phase II Trials
100%
Placebo
60%
Randomized Controlled Trial
20%
Recombinant Nerve Growth Factor
100%
Sensory Neuropathy
100%
Subcutaneous Injection
20%